This profile was last updated on .
Is this you? Claim your profile.
+ Get 10 Free Contacts a Month
Please agree to the terms and conditions
Head of the Department of Medical Cell Biophysics
MESA+ Institute for Nanotechnology & BMTI Institute for Biomedical Technology, University of Twente
Senior Vice President ( Research and Development
Associate Scientific Director
Becton Dickinson Immunocytometry Systems
Groningen University Medical School
AcZon - FP7 Project
FP7 projects | Asper Biotech
Program | Nanobiotech
Biotechnology news â€“ media center | Asper Biotech
The new and highly advanced technique known as the CTCtrap aims to screen cancer patients for circulating tumor cells (CTC) in the future, and thereby to provide therapy that is better tailored to individual patients.
The CTCtrap is expected to be available in about four years' time.
According to Prof. Terstappen, "this new technology will bring about a radical change in the treatment of cancer patients."
Leidos Holdings, Inc.
ACES North America Inc
Terstappen Autovermietung GmbH